*Pages 1--1 from  Microsoft Word - 58355.doc*
 STATEMENT  OF  CHAIRMAN  KEVIN  J.  MARTIN 
 Re:  In  the  Matter  of  Investigation  of  the  Spectrum  Requirements  for  Advanced  Medical  Technologies;  Amendment  of  Parts  2  and  95  of  the  Commission’s  Rules  to  Establish  the 
 Medical  Device  Radio  Communications  Service  at  401-  402  and  405-  406  MHz;  DexCom,  Inc.  Request  for  Waiver  of  the  Frequency  Monitoring  Requirements  of  the  Medical 
 Implant  Communications  Service  Rules;  Biotronik,  Inc.  Request  for  Waiver  of  the  Frequency  Monitoring  Requirements  for  the  Medical  Implant  Communications  Service 
 Rules  (ET  Docket  Nos.  06-  135,  05-  213,  03-  92,  and  RM  11271),  FCC  06-  103 


 The  use  of  wireless  technologies  in  implantable  and  body-  worn  medical  devices  is  improving  and  extending  patients’  lives.  Today’s  item  supports  continued  development  and  deployment  of  these 
 devices  by  proposing  the  allocation  of  additional  spectrum  and  greater  flexibility  for  medical  radio  devices.  As  demand  for  more  advanced  medical  devices  increases,  we  should  also  be 
 prepared  to  facilitate  next-  generation  solutions  and  to  work  with  the  Food  and  Drug  Administration  and  other  agencies  that  play  a  role  in  their  evolution.  Our  requests  for 
 information  on  new  medical  radio  technologies  and  inter-  agency  collaboration  will  help  us  better  anticipate  future  developments  in  this  field  of  medicine  and  thereby  provide  the  best  healthcare 
 possible  for  patients  today  and  tomorrow. 
1